Chronisch Vermoeidheidssyndroom: diagnose, behandeling en ...

KCE Reports 88 Chronic Fatigue Syndrome 121
95. Deale A, Husain K, Chalder T, S. W. Long-term outcome of cognitive behavior therapy
versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J
Psychiatry. 2001;158(12):2038-42.
96. Friedberg F, Krupp LB. A comparison of cognitive behavioral treatment for chronic fatigue
syndrome and primary depression. Clin Infect Dis. 1994;18:S105-10.
97. Taylor RR. Quality of life and symptom severity for individuals with chronic fatigue
syndrome: findings from a randomized clinical trial. Am J Occup Ther. 2004;58(1):35-43.
98. Cox D. An evaluation of an occupational therapy inpatient intervention for chronic fatigue
syndrome. London: King's College London; 1999.
99. Cox D. Chronic fatigue syndrome: An evaluation of an occupational therapy inpatient
intervention. Br J Occup Ther. 2002;65:461-68.
100. Viner R, Gregorowski A, Wine C BM, Fisher D, Miller M, al. e. Outpatient rehabilitative
treatment of chronic fatigue syndrome (CFS/ME). Arch Dis Child. 2004;89:615-9.
101. Bazelmans E, Prins JB, Lulofs R, van der Meer JWM, Bleijenberg G, The Netherlands Fatigue
Research Group N. Cognitive behaviour group therapy for chronic fatigue syndrome: a nonrandomised
waiting list controlled study.[see comment]. Psychotherapy & Psychosomatics.
2005;74(4):218-24.
102. Quarmby L, Rimes KA, Deale A, Wessely S, Chalder T. Cognitive-behaviour therapy for
chronic fatigue syndrome: Comparison of outcomes within and outside the confines of a
randomised controlled trial. Behaviour Research and Therapy. Vol. 2007;45(6):1085-94.
103. Huibers M, Beurskens A, Van Schayck C, Bazelmans E, Metsemakers J, Knottnerus A, et al.
Efficacy of cognitive behavioral therapy by general practitioners for unexplained fatigue
among employees. Randomized controlled trial. Br J Psychiatry. 2004;184:240-6.
104. Chalder T, Wallace DJ, Wessely S. Self-help treatment of chronic fatigue in the community: A
randomized controlled trial. Br J Health Psychol. 1997;2:189-97.
105. Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane
Database of Systematic Reviews. 2004;3(3):CD003200.
106. Devanur LD, Kerr JR. Chronic fatigue syndrome. J Clin Virol. 2006;37(3):139-50.
107. White PD, Thomas JM, Kangro HO, Bruce-Jones WD, Amess J, Crawford DH, et al.
Predictions and associations of fatigue syndromes and mood disorders that occur after
infectious mononucleosis. Lancet. 2001;358(9297):1946-54.
108. Buchwald DS, Rea TD, Katon WJ, Russo JE, Ashley RL. Acute infectious mononucleosis:
characteristics of patients who report failure to recover. Am J Med. 2000;109(7):531-7.
109. Steinberg P, McNutt BE, Marshall P, Schenck C, Lurie N, Pheley A, et al. Double-blind
placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic
fatigue syndrome. J Allergy Clin Immunol. 1996;97:119-26.
110. Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, et al. Acyclovir treatment of the
chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med.
1988;319:1692-8.
111. Lerner AM, Zervos M, Chang CH, Beqaj S, Goldstein J, O'Neill W, et al. A small,
randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic
fatigue syndrome. Clin Infect Dis. 2001;32:1657-8.
112. Diaz-Mitoma F, Turgonyi E, Kumar A, Lim W, Larocque L, Hyde B. Clinical improvement in
chronic fatigue syndrome is associated with enhanced natural killer cell-mediated
cytotoxicity: the results of a pilot study with Isoprinosine. J Chronic Fatigue Syndr.
2003;11:71-93.
113. Lloyd A, Hickie I, Wakefield D, Boughton C, J. D. A double-blind, placebo-controlled trial of
intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med.
1990;89:561-8.